B2B publication BioProcess International (BPI) has announced the launch of BioProcess International Digital Media Expertise On-Demand. BPI is dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics.
BioProcess International Digital Media (BPIDM) is an interactive experience providing biopharmaceutical professionals with exclusive online access to leading industry experts perspective and insight on the latest science, technologies, and business trends impacting the development and manufacturing of biotherapeutics.
BPIDM is a unique compilation of conference presentations, digitally recorded and presented on-demand, says Christopher Johnson, BPIs Director of Electronic Media Development. BPIDM provides scientists with a second opportunity to listen and experience many of the presentations they could not attend in person.
Current audiocasts on BPIDM are based upon the presentations from the 2012 BioProcess Theater that took place over a 3-day period at the 2012 BIO International Convention, June 2012 covering: Biosimilars, Upstream Processing, Downstream Processing, Manufacturing, and Cell Therapies. New content and presentations will be added every month.
BioProcess International is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process.
